@misc{indiciae17582d9c9ad3,
  title = {Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta-regression analysis incorporating FLOW and SOUL trials.},
  author = {Masashi Hasebe and Chen-Yang Su and Yamato Keidai and Hiroto Minamino and Daisuke Yabe and Nobuya Inagaki and Satoshi Yoshiji},
  year = {2025},
  doi = {10.1111/dom.70121},
  url = {https://pubmed.ncbi.nlm.nih.gov/40926380/},
  note = {Source identifier: 40926380}
}